Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 218 More Arrow 356 Less Arrow 197
Earnings before taxes -9,878 Less Arrow -11,965 Less Arrow -12,665
EBITDA -9,901 Less Arrow -13,116 Less Arrow -13,388
Total assets 7,847 More Arrow 19,641 More Arrow 32,609
Current assets 2,608 More Arrow 14,456 More Arrow 26,852
Current liabilities 1,133 More Arrow 3,371 Less Arrow 2,455
Equity capital 6,699 More Arrow 16,252 More Arrow 30,100
- share capital 3,143 Less Arrow 3,134 More Arrow 3,381
Employees (average) 23 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 85.4% Less Arrow 82.7% More Arrow 92.3%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -123.1% More Arrow -59.1% More Arrow -38.2%
Current ratio 230.2% More Arrow 428.8% More Arrow 1093.8%
Return on equity (ROE) -147.5% More Arrow -73.6% More Arrow -42.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 1 More Arrow 2 More Arrow 9
Chg. No. of employees % 5% More Arrow 10% More Arrow 82%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.